Biosciences Division

News

• New ORNL process brings nanoparticles into focus

  Scientists can study the biological impacts of engineered nanomaterials on cells within the body with greater resolution than ever because of a procedure developed by researchers at the Department of Energy's Oak Ridge National Laboratory.

• Audio Spot: New medicine therapeutics company is spinout from ORNL

  A Company, NellOne Therapeutics, has been formed through Battelle Ventures to research the potential for a new therapy that could help heart patients, according to Oak Ridge National Laboratory scientist Cymbeline Culiat.

Genome Analysis and Systems Modeling Group

One of our primary goals is to design, implement, and provide practical computational tools for the analysis and annotation of genomes. The group is working on developing state-of-the-art tools for genomic analysis including gene finding, with a special focus on systems for retrieval, assembly, analysis, and annotation of the ever-increasing DNA sequence data that is being generated by sequencing centers around the world.

Another goal is to provide information required for advances in biological research by developing an underlying data and computer system infrastructure that supports improved access to:

• biological information resulting from research and analysis;
• biological data and information needed for research and analysis; and
• biological, bioinformatics, and computational resources and tools.

Further details are on the website. http://compbio.ornl.gov/public/section/genome.html

(Contact: Miriam L. Land, landml@ornl.gov, 865-241-6231 )